Cosentyx is a prescription medication approved by the Food and Drug Administration (FDA) to treat adults 18 and older who have active psoriatic arthritis or moderate to severe plaque psoriasis. Cosentyx is also known by its drug name, Secukinumab.
Cosentyx is an immunomodulator, or, in other words, a drug that modulates the immune system. It is also considered a biologic. Cosentyx is a genetically engineered antibody, a type of protein used by the immune system to identify and neutralize substances. Cosentyx is believed to work by targeting specific proteins in the immune system and reducing inflammation.
How do I take it?
Cosentyx is injected subcutaneously once a week for the first five weeks, then once a month.
Cosentyx comes as a single-use prefilled pen or syringe.
The FDA-approved label for Cosentyx lists common side effects including diarrhea, cold symptoms, and upper respiratory infections.
Rare but serious side effects listed for Cosentyx include inflammatory bowel disease, hypersensitivity reactions, and severe infections including tuberculosis.